DE3872382T2 - Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung. - Google Patents
Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.Info
- Publication number
- DE3872382T2 DE3872382T2 DE8888120153T DE3872382T DE3872382T2 DE 3872382 T2 DE3872382 T2 DE 3872382T2 DE 8888120153 T DE8888120153 T DE 8888120153T DE 3872382 T DE3872382 T DE 3872382T DE 3872382 T2 DE3872382 T2 DE 3872382T2
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical compositions
- production
- extended effect
- active substance
- microporous support
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8820145A IT1216570B (it) | 1988-04-08 | 1988-04-08 | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3872382D1 DE3872382D1 (de) | 1992-07-30 |
DE3872382T2 true DE3872382T2 (de) | 1992-12-10 |
Family
ID=11164167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8888120153T Expired - Fee Related DE3872382T2 (de) | 1988-04-08 | 1988-12-02 | Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5008114A (de) |
EP (1) | EP0336014B1 (de) |
AT (1) | ATE77547T1 (de) |
DE (1) | DE3872382T2 (de) |
ES (1) | ES2042700T3 (de) |
IT (1) | IT1216570B (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5290570A (en) * | 1989-05-30 | 1994-03-01 | Purepac, Inc. | Lotions containing liquid-loaded powder |
FR2694701B1 (fr) * | 1990-04-18 | 1996-01-19 | Biagianti Irene | Application des zeolithes naturelles a l'homme et a l'environnement. |
IT1243745B (it) * | 1990-10-17 | 1994-06-21 | Vectorpharma Int | Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione. |
US5225204A (en) * | 1991-11-05 | 1993-07-06 | Chen Jivn Ren | Stable dosage of levothyroxine sodium and process of production |
US5409903A (en) * | 1992-02-18 | 1995-04-25 | Urecap Corporation | Method and compositions for the treatment of H. pylori and dermatitis |
US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
AU4932493A (en) * | 1992-09-25 | 1994-04-26 | Dynagen, Inc. | An immunobooster for delayed release of immunogen |
EP0669128B1 (de) * | 1992-11-17 | 2000-01-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung |
CA2151260A1 (en) * | 1993-02-23 | 1994-09-01 | Pankaj B. Gala | A process for the preparation of substantially alcohol free pharmaceutical compositions |
ATE288270T1 (de) * | 1993-11-19 | 2005-02-15 | Janssen Pharmaceutica Nv | Mikroverkapselte 1,2-benzazole |
DE4416001C2 (de) * | 1994-05-06 | 1997-12-11 | Feinchemie Gmbh Sebnitz | Komposite zur steuerbaren Wirkstoff-Freisetzung |
CA2213638C (en) * | 1995-02-24 | 2004-05-04 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
US6764690B2 (en) | 1996-05-29 | 2004-07-20 | Delsitech Oy | Dissolvable oxides for biological applications |
ATE301102T1 (de) * | 1996-05-29 | 2005-08-15 | Delsitech Oy | Lösliche oxide für biologische anwendungen |
US7101575B2 (en) | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US6524620B2 (en) | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
NZ513013A (en) * | 1999-02-22 | 2002-11-26 | Bioxid Oy | Biodegradable ceramic fibres from silica sols useful in delivery devices for biologically active agents |
GB9904485D0 (en) * | 1999-02-27 | 1999-04-21 | Procter & Gamble | Method for protecting and/or controlled release of active ingredient |
ATE226267T1 (de) * | 1999-06-10 | 2002-11-15 | Max Planck Gesellschaft | Einkapselung von kristallen mit mehrschichtigem überzug |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
EP1269994A3 (de) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten |
KR100759635B1 (ko) * | 2001-06-22 | 2007-09-17 | 화이자 프로덕츠 인코포레이티드 | 비정질 약물의 흡착체의 약학 조성물 |
ATE395044T1 (de) | 2002-02-01 | 2008-05-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
US20040132771A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Inc | Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors |
ATE540671T1 (de) | 2003-08-04 | 2012-01-15 | Bend Res Inc | Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien |
US7387793B2 (en) * | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
DE102004013637A1 (de) | 2004-03-19 | 2005-10-13 | Capsulution Nanoscience Ag | Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln |
FI20070174A0 (fi) * | 2007-02-28 | 2007-02-28 | Delsitech Oy | Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt |
ITMI20071930A1 (it) * | 2007-10-05 | 2009-04-06 | Sasol Italy S P A | Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso |
NO2403482T3 (de) | 2009-03-04 | 2018-05-26 | ||
JP5691051B2 (ja) | 2009-05-08 | 2015-04-01 | エンプリキュア・アクチエボラゲット | ジオポリマー結合剤を含む持続薬物送達用組成物 |
KR20140003405A (ko) | 2010-09-07 | 2014-01-09 | 오렉쏘 에이비 | 경피 약물 투여 장치 |
US9526701B2 (en) * | 2011-12-20 | 2016-12-27 | Keith R. Latham | Sustained drug release and improved product stability using non-covalent particle coating methods |
US10835495B2 (en) | 2012-11-14 | 2020-11-17 | W. R. Grace & Co.-Conn. | Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same |
WO2015153613A1 (en) * | 2014-03-31 | 2015-10-08 | Massachusetts Institute Of Technology | Porous materials containing compounds including pharmaceutically active species |
GB201502073D0 (en) | 2015-02-09 | 2015-03-25 | Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd | HDEG technology |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923969A (en) * | 1973-06-12 | 1975-12-02 | Battelle Institut E V | Carrier system for a drug with sustained release |
US4013785A (en) * | 1975-03-21 | 1977-03-22 | Bristol-Myers Company | Apap tablet containing fumed silica and process for manufacturing same |
DE2845326C2 (de) * | 1978-10-18 | 1985-05-23 | Beiersdorf Ag, 2000 Hamburg | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung |
US4834978A (en) * | 1984-10-01 | 1989-05-30 | Biotek, Inc. | Method of transdermal drug delivery |
GB8606468D0 (en) * | 1986-03-15 | 1986-04-23 | Sds Biotech Uk Ltd | Therapeutic compositions |
US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
JPS6327502A (ja) * | 1986-07-22 | 1988-02-05 | Agency Of Ind Science & Technol | シクロデキストリン−シリカ複合体及びその製造方法 |
-
1988
- 1988-04-08 IT IT8820145A patent/IT1216570B/it active
- 1988-11-28 US US07/276,489 patent/US5008114A/en not_active Expired - Fee Related
- 1988-12-02 EP EP88120153A patent/EP0336014B1/de not_active Expired - Lifetime
- 1988-12-02 DE DE8888120153T patent/DE3872382T2/de not_active Expired - Fee Related
- 1988-12-02 AT AT88120153T patent/ATE77547T1/de not_active IP Right Cessation
- 1988-12-02 ES ES88120153T patent/ES2042700T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0336014A1 (de) | 1989-10-11 |
ATE77547T1 (de) | 1992-07-15 |
EP0336014B1 (de) | 1992-06-24 |
IT1216570B (it) | 1990-03-08 |
IT8820145A0 (it) | 1988-04-08 |
US5008114A (en) | 1991-04-16 |
ES2042700T3 (es) | 1993-12-16 |
DE3872382D1 (de) | 1992-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3872382T2 (de) | Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung. | |
SE8305535L (sv) | Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav | |
ES2054613T3 (es) | Un metodo para preparar una formulacion de liberacion mantenida. | |
DE69010668T2 (de) | Verkapselung von sucralose aus lösungen mit polyvinylacetat zur verwendung in kaugummi. | |
ATE103914T1 (de) | Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen. | |
MA21182A1 (fr) | Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant. | |
FI943205A0 (fi) | Menetelmä jatkuvasti vapauttavien valmisteiden valmistamiseksi | |
ATE87235T1 (de) | Verfahren zur herstellung von mikrokapseln. | |
ATE71375T1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
DK0461630T3 (da) | Fremgangsmåde til fremstilling af mikrokugler | |
ATE38834T1 (de) | 5-substituierte 1,2,4-oxadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
IT1224405B (it) | Composti attivi sul sistema cardiovascolare | |
ATE5188T1 (de) | Phenylalkansaeure-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE68906572D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
NO883520D0 (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
ES2051731T3 (es) | Un procedimiento para preparar antibioticos macrolidos y su uso. | |
DE3676491D1 (de) | Gelatinekapseln mit gesteuerter wirkstofffreisetzung und verfahren zur herstellung derselben. | |
DE3881484D1 (de) | Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE106407T1 (de) | Derivate von thiazolidin-4-carbonsäure, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE100102T1 (de) | Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
PT87628A (pt) | Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives | |
NO870950D0 (no) | Fremgangsmaate for fremstilling av et stabilt injiserbart farmasoeytisk preparat. | |
ATE104848T1 (de) | Trapidil enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. | |
KR870010872A (ko) | 루프성 이뇨제의 경피 치료 시스템용 조성물의 제조방법 | |
DE68909451D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Free format text: HANKE, H., DIPL.-ING. DIPL.-WIRTSCH.-ING., PAT.-ANW., 80802 MUENCHEN |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT |
|
8328 | Change in the person/name/address of the agent |
Free format text: DERZEIT KEIN VERTRETER BESTELLT |
|
8339 | Ceased/non-payment of the annual fee |